Multifunctionality of lipid-core micelles for drug delivery and tumour targeting

Phospholipid micelles have proven to be the versatile pharmaceutical nanocarrier of choice for the delivery of poorly soluble chemotherapeutics for cancer therapy using various treatment modalities. Phospholipid micelles are typically expected to increase the accumulation of the loaded drugs in tumour tissues by taking advantage of the enhanced permeability and retention effect and by ligand-mediated active targeting. Furthermore, by tailoring the composition of the micelles, it is possible to enhance the intracellular delivery of the cargo. This review highlights the important advancements in our laboratory with polyethyleneglycol phosphatidylethanolamine (PEG-PE)-based micellar drug delivery systems for improvement of the therapeutic efficacy of poorly soluble anticancer drugs.     

Application quantum and physico chemical molecular descriptors utilizing principal components to study mode of anticoagulant activity of pyridyl chromen-2-one derivatives

Factors II, V, VII and Xa have materialized as a key enzymes for the intervention of blood coagulation cascade and for the development of new anti thrombotic agents. The combined density functional quantum mechanical/molecular mechanical (QM/MM) approach has been used to access inhibition of prothrombin and thrombin production. The biological activities of coumarin derivatives as clotting factor inhibitors was quantitatively analyzed in terms of physicochemical parameters utilizing the principal component analysis. Structural requirements for maximal potency were derived from the results of a quantitative structure activity relationship analysis.     

Copper(I) complexes with Schiff base and 1,2-bis(diphenylphosphino)ethane as ligands: Synthesis, structure and catalytic properties for the amination of aryl halide

Some copper(I) complexes of the type [Cu(L)(dppe)]X (1-4) [where L = (3-trifluoromethylphenyl)pyridine-2-ylmethylene-amine; dppe = 1,2-bis(diphenylphosphino)ethane; X = Cl⁻, CN⁻, ClO₄⁻ and BF₄⁻] have been synthesized by the condensation of 3-aminobenzotrifluoride with 2-pyridinecarboxaldehyde followed by the reaction with CuCl, CuCN, [Cu(MeCN)₄]ClO₄ and [Cu(MeCN)₄]BF₄ in presence of dppe. The complexes 1-4 were then characterized on the basis of elemental analysis, IR, UV-Vis and ¹H NMR spectral studies. The representative complex of the series 4 has been characterized by single crystal X-ray diffraction which reveal that in complex the central copper(I) ion assumes the irregular pseudo-tetrahedral geometry. The catalytic activity of the complexes was tested and it was found that all the complexes worked as effective catalyst in the amination of aryl halide.     

Bibersteinia trehalosi Inhibits the Growth of Mannheimia haemolytica by a Proximity-Dependent Mechanism

Mannheimia (Pasteurella) haemolytica is the only pathogen that consistently causes severe bronchopneumonia and rapid death of bighorn sheep (BHS; Ovis canadensis) under experimental conditions. Paradoxically, Bibersteinia (Pasteurella) trehalosi and Pasteurella multocida have been isolated from BHS pneumonic lungs much more frequently than M. haemolytica. These observations suggest that there may be an interaction between these bacteria, and we hypothesized that B. trehalosi overgrows or otherwise inhibits the growth of M. haemolytica. Growth curves (monoculture) demonstrated that B. trehalosi has a shorter doubling time (∼10 min versus ∼27 min) and consistently achieves 3-log higher cell density (CFU/ml) compared to M. haemolytica. During coculture M. haemolytica growth was inhibited when B. trehalosi entered stationary phase (6 h) resulting in a final cell density for M. haemolytica that was 6 to 9 logs lower than expected with growth in the absence of B. trehalosi. Coculture supernatant failed to inhibit M. haemolytica growth on agar or in broth, indicating no obvious involvement of lytic phages, bacteriocins, or quorum-sensing systems. This observation was confirmed by limited growth inhibition of M. haemolytica when both pathogens were cultured in the same media but separated by a filter (0.4-μm pore size) that limited contact between the two bacterial populations. There was significant growth inhibition of M. haemolytica when the populations were separated by membranes with a pore size of 8 μm that allowed free contact. These observations demonstrate that B. trehalosi can both outgrow and inhibit M. haemolytica growth with the latter related to a proximity- or contact-dependent mechanism.The bighorn sheep (BHS; Ovis canadensis) population in North America has declined from an estimated two million at the beginning of the 19th century to fewer than 70,000 today (7, 30). The decline of BHS populations is presumably due to loss of habitat, competition for forage with domestic livestock, predation, and disease (9, 19). The most important disease that has limited the growth of BHS populations is pneumonia (13, 14, 19, 31). Bacteria associated with BHS pneumonia are members of the genera Mannheimia and Pasteurella, particularly, the species Mannheimia (Pasteurella) haemolytica, Bibersteinia (Pasteurella) trehalosi, and Pasteurella multocida (6-9, 15, 20, 25, 31). Several independent studies have revealed that M. haemolytica is a major cause of BHS pneumonia. In fact, M. haemolytica is the only pathogen that has been shown to consistently cause severe bronchopneumonia and rapid death of BHS under experimental conditions (10, 14, 23). B. trehalosi has been isolated more often than M. haemolytica from the upper respiratory tract of healthy BHS (10, 12-14, 26, 31). Large numbers of B. trehalosi have also been isolated from the pneumonic lungs of BHS experimentally inoculated with M. haemolytica alone (10). Furthermore, our recent studies with M. haemolytica wild type and leukotoxin deletion mutants in BHS have revealed that the leukotoxin deletion mutant does not cause the death of BHS but instead induces only mild lung lesions, confirming the finding in cattle that leukotoxin is the most important virulence factor of M. haemolytica (10, 24, 29). Our recently concluded BHS inoculation study revealed that only leukotoxin producing strains of B. trehalosi can cause pneumonia, indicating that leukotoxin is the most important virulence determinant in B. trehalosi as well. More than 85% of the B. trehalosi isolates obtained from BHS, however, do not produce leukotoxin (28, 32). Therefore, this observation, together with the results from the animal experiments, indicates that B. trehalosi is unlikely to be the major cause of pneumonia outbreaks in BHS.These observations prompted us to hypothesize that B. trehalosi outgrows or otherwise inhibits the growth of M. haemolytica. The objectives of the present study were to (i) characterize in vitro growth kinetics of M. haemolytica and B. trehalosi; (ii) develop M. haemolytica-specific and B. trehalosi-specific PCR assays to detect either species in mixed cultures; and (iii) determine whether B. trehalosi inhibits the growth of M. haemolytica in vitro and, if it does, characterize the mechanism of inhibition.     

Omphalocele,exstrophy of cloaca,imperforate anus and spinal defect (OEIS Complex) with overlapping features of body stalk anomaly (limb body wall complex)

OEIS is an extremely rare constellation of malformations, which includes omphalocele, exstrophy of cloaca, imperforate anus, and spinal defect. We report here autopsy findings in a case of OEIS complex, which apart from the major anomalies of the complex had bilateral club foot that is, congenital talipes equinovarus, right hydroureter, and body stalk anomaly. The umbilical cord was absent, and the umbilical vessels were embedded in an amniotic sheet, which connected the skin margin of the anterior body wall defect to the placenta, this feature being the hallmark of limb body wall complex (LBWC). This case further supports the view that OEIS and LBWC represent a continuous spectrum of abnormalities rather than separate conditions and may share a common etiology and pathogenetic mechanism as proposed by some authors.     

Dynamic myosin activation promotes collective morphology and migration by locally balancing oppositional forces from surrounding tissue

Migrating cells need to overcome physical constraints from the local microenvironment to navigate their way through tissues. Cells that move collectively have the additional challenge of negotiating complex environments in vivo while maintaining cohesion of the group as a whole. The mechanisms by which collectives maintain a migratory morphology while resisting physical constraints from the surrounding tissue are poorly understood. Drosophila border cells represent a genetic model of collective migration within a cell-dense tissue. Border cells move as a cohesive group of 6−10 cells, traversing a network of large germ line–derived nurse cells within the ovary. Here we show that the border cell cluster is compact and round throughout their entire migration, a shape that is maintained despite the mechanical pressure imposed by the surrounding nurse cells. Nonmuscle myosin II (Myo-II) activity at the cluster periphery becomes elevated in response to increased constriction by nurse cells. Furthermore, the distinctive border cell collective morphology requires highly dynamic and localized enrichment of Myo-II. Thus, activated Myo-II promotes cortical tension at the outer edge of the migrating border cell cluster to resist compressive forces from nurse cells. We propose that dynamic actomyosin tension at the periphery of collectives facilitates their movement through restrictive tissues.     

Levels of acute phase proteins remain stable after ischemic stroke

Background  

Inflammation and inflammatory biomarkers play an important role in atherosclerosis and cardiovascular disease. Little information is available, however, on time course of serum markers of inflammation after stroke.